Nortriptyline and the Risk of Serious Adverse Events | MicrobiomeTrials← Back to trialsNCT07527481
Nortriptyline and the Risk of Serious Adverse Events
CompletedOBSERVATIONAL
Trial Details
Start: 2008-01-01Est. Completion: 2025-12-01
Enrollment target: 5,000 participants Other microbiome trials you might be interested in
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic MalignanciesDysmyelopoietic Syndromes
Hematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
Diet TherapyHealthy Volunteers
Background:
Diet is one of the most modifiable behaviors affecting health. But diet assessment measures that are based …
Phoenix, United StatesEst. completion Jan 1, 2028